Skip to main content

Healthy Chinese Subjects

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Milestone Pharmaceuticals
1 program
1
Etripamil Nasal Spray 70mgPhase 11 trial
Active Trials
NCT05511870Completed12Est. Mar 2023

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
Milestone PharmaceuticalsEtripamil Nasal Spray 70mg

Clinical Trials (1)

Total enrollment: 12 patients across 1 trials

NCT05511870Milestone PharmaceuticalsEtripamil Nasal Spray 70mg

A Study of Etripamil in Healthy Subjects

Start: Mar 2023Est. completion: Mar 202312 patients
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.